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Abstract
Background: Sevoflurane preconditioning (SPC) against myocardial ischemia-reperfusion
injury is lost if the ischemic insult is too long. Emerging evidence suggests that induction of
autophagy may also confer cardioprotection against ischemia-reperfusion injury. We
examined whether induction of autophagy prolongs SPC protection during a longer ischemic
insult.
Methods: Isolated guinea pigs hearts were subjected to 30 or 45 min ischemia, followed by
120 min reperfusion (control). Anesthetic preconditioning was elicited with 2% sevoflurane
for ten minutes prior to ischemia (SEVO-30, SEVO-45). Chloramphenicol (autophagy
upregulator, 300 µM) was administered starting 20 min before ischemia and throughout
reperfusion in SEVO-45 (SEVO-45+CAP). To inhibit autophagy, 3-methyladenine
(3MA:10 µM) was administered during sevoflurane administration in SEVO-45+CAP.
Infarct size was determined by triphenyltetrazolium chloride stain. Tissue samples were
obtained before ischemia to determine autophagy-related protein (microtubule-associated
protein light chain I and II: LC3-I, II), Akt and glycogen synthase kinase 3β (GSK3β)
expression using Western blot analysis. The effect of autophagy on calcium-induced
mitochondrial permeability transition pore (MPTP) opening in isolated calcein-loaded
mitochondria was assessed. Electron microscopy was used to detect autophagosomes.
Results: Infarct size was significantly reduced in SEVO-30, but not in SEVO-45.
Chloramphenicol restored SPC lost by 45 min ischemia. There were more abundant
autophagozomes and LC3-II expression was significantly increased in SEVO-45+CAP.
Induction of autophagy before ischemia enhanced GSK3β phosphorylation and inhibition of
calcium-induced MPTP opening. These effects were abolished by 3MA.
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Conclusions: Pre-ischemic induction of autophagy restores SPC lost by longer ischemic
insult. This effect is associated with enhanced inhibition of MPTP by autophagy.

Key Words:
autophagy, chloramphenicol, ischemia-reperfusion, preconditioning, sevoflurane
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Introduction
Experimental1-3 and clinical studies4,5 have demonstrated the use of volatile
anesthetics as an additional therapeutic approach in the care of patients at risk of developing
perioperative cardiac complications; known as volatile anesthetic preconditioning.6,7 The
washout time of volatile anesthetics prior to ischemia8 and the duration of sustained
ischemia9,10 have been shown to be crucial to successful volatile anesthetic cardioprotection.
Kevin et al. demonstrated that sevoflurane cardioprotection is restricted to a range of
ischemic durations of 25-40 min in isolated guinea pig hearts.9 Similarly, the neuroprotective
effects of clinically relevant sevoflurane concentrations was observed only for ischemia of
≤30

minutes.10

Finding strategies

that

prolong cardioprotection

by sevoflurane

preconditioning during longer ischemic insults could be clinically useful.
Autophagy is a catabolic process through which damaged or long-lived protein and
organelles are degraded using lysosomal degradative pathways. This is an evolutionally
conserved process crucial for normal tissue homeostasis. Autophagy is considered one mode
of cell death, termed “autophagic cell death”. Certainly, necrosis and apoptosis contribute to
cardiomyocyte death in ischemia-reperfusion injury. However, accumulating evidence
suggests that autophagy is stimulated by ischemia and may contribute to cardiomyocyte
survival.12,13 Yet, excessive self-digestion and degradation of essential cellular components
by autophagy could be detrimental.14 To date, it is unclear whether upregulation of
autophagy is protective or detrimental for ischemic myocardium.
Autophagy is triggered by opening of mitochondrial permeability transition pores
(MPTP), which also play an important role in myocardial ischemia-reperfusion injury.15
Studies have shown that inactivation of glycogen synthase kinase 3β (GSK3β) by
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phosphorylation at Ser9 inhibits MPTP opening and protects cardiomyocytes against
ischemia-reperfusion injury.16 It is not known whether pre-ischemic induction of autophagy
affects MPTP. We hypothesized that pre-ischemic induction of autophagy restores loss of
sevoflurane preconditioning seen with prolonged ischemic insult and this effect is associated
with MPTP opening. Elucidating the role of autophagy in ischemia-reperfusion injury and
finding strategies that prolong cardioprotection by sevoflurane preconditioning during longer
ischemic insults could prove clinically useful in patients at cardiovascular risk during
perioperative periods.
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Methods
This study was conducted in accordance with the Guidelines for Animal Research at
Osaka Dental University with approval of the Animal Experiment Committee of Osaka
Dental University, Osaka, Japan. These guidelines conform to the Guide for the Care and
Use of Laboratory Animals from the National Academy of Science. Male Hartley guinea
pigs were fed Lab Diet (RC4, Oriental Yeast, Tokyo, Japan) and water ad libitum.
Chloramphenicol was purchased from Calbiochem (La Jolla, CA, USA) to induce
autophagy. 3-methyladenine (3MA) was purchased from Sigma Aldrich (Ann Arbor, MI,
USA) to inhibit autophagy.

Isolated Heart Perfusion and Measurement of Function
Guinea pigs (550-700g; 12-13 weeks old) received heparin (1000 units
intraperitoneally), then were anesthetized with pentobarbital (60 mg-1kg-1, intraperitoneally).
Hearts were excised and arrested in cold iso-osmotic saline containing 20 mM KCl. The
aorta was cannulated and hearts were perfused at 70 mmHg on a nonrecirculating
isovolumic perfusion apparatus, using Krebs-Henseleit perfusate, and paced at 240
beats/min.3 Left ventricular developed pressure (LVDP) was measured using a 2.5 French,
high-fidelity micromanometer (Nihon-Kohden, Tokyo, Japan) passed into a compliant latex
balloon, inserted into the left ventricle, and recorded on a PowerLab 2/20 Data Recording
System (ADInstruments, Hayward, Australia). The balloon was connected to a Y-adapter
with one end used to advance the micromanometer and the other to fill the left ventricular
balloon with bubble-free water to an end-diastolic pressure (LVEDP) of 10 mmHg.
Coronary flow (CF) (mlmin-1g-1) was measured by collecting effluent. Global ischemia
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was achieved by clamping the aortic inflow line. During ischemia, hearts were maintained at
37 °C by enclosure in a water-jacketed air chamber. Warmed perfusate in the lower part of
the chamber saturated the air with humidity and prevented cooling by evaporation. Heart
temperature was continuously monitored by a digital thermometer (PTW-100A, Unique
Medical, Tokyo, Japan). Sevoflurane was insufflated passing the 95%O2/5%CO2 gas
mixture through a calibrated vaporizer (ACOMA, Tokyo, Japan). Coronary perfusate
samples were collected anaerobically from the aortic cannula for measurement of
sevoflurane concentration by an organic vapor sensor (OSP, Saitama, Japan).

Experimental Protocol
Animals were assigned 10 groups (n=8 each; Figure 1). After 20 min equilibration,
baseline LVDP, LVEDP and CF were recorded. Hearts were subjected to 30 min (control;
CTL-30) or 45 min (control; CTL-45) ischemia followed by 120 min reperfusion.
Anesthetic preconditioning was elicited by administration of sevoflurane (2%) for 10 min
followed by 10 min washout before 30 min or 45 min ischemia (SEVO-30, SEVO-45). For
induction of autophagy, chloramphenicol (300 µM) was administered starting 20 min before
45 min ischemia and throughout reperfusion in sevoflurane-treated (SEVO-45+CAP) or
non-sevoflurane-treated animals (CAP-45) hearts. To inhibit autophagy, 3MA (10 µM) was
administered during sevoflurane administration for 20 min in SEVO-45+CAP (SEVO45+CAP+3MA) and its vehicle (saline) in CTL-45 (CTL-45+3MA) (Figure 1).
Chloramphenicol was dissolved in distilled water and 3MA was dissolved in 0.04% ethanol,
to final concentrations of 300 µM and 10 µM, respectively.
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Determination of Myocardial Infarct Size
At experiment end, hearts were frozen at –80 °C for 15 min, then sliced into 2 mm
thick transverse sections from apex to base (6 slices/heart). After defrosting, slices were
incubated at 37 °C with 1% triphenyltetrazolium chloride (Sigma Chemicals, USA)
photographed, and necrotic area was determined using Adobe Photoshop® CS (Adobe, San
Jose, CA, USA) as previously described.3

Western Blot Analysis
Separate experiments were performed (n=4 per group) to examine expression of
autophagy-related protein (microtubule-associated protein light chain I and II: LC3-I, II), Akt,
GSK3β and cyclophilin D. Myocardial tissue samples were collected before ischemia, and
homogenized in ice-cold homogenizing buffer as previously described.3 Homogenate was
centrifuged at 1000g for 5 min at 4 °C. Supernatant was re-centrifuged at 10000g for 15 min at
4 °C to obtain cytosolic fraction. The pellet was designated as crude mitochondrial fraction
and was resuspended in homogenizing buffer with 1% TritonX-100, incubated on ice for 1hr,
then re-centrifuged at 10000g for 15 min at 4 °C. The resulting supernatant was used as
mitochondrial fraction. Protein concentration was estimated with a Bradford assay. Equivalent
amounts (20 µg) of protein samples were loaded and separated on 10% SDS-PAGE gradient
gel, then electrically transferred overnight to a polyvinylidene difluoride membrane (Bio-Rad,
Hercules, CA). After blocking with 5% skim milk in Tris-buffered saline containing 0.1%
Tween-20 (TBS-T), membranes were incubated for 2 h at 4 °C in TBS-T containing 5% skim
milk and overnight with 1:200-1000 dilution of rabbit primary antibody for LC3 (Medical &
Biological Laboratories Co LTD, MA, USA), phospho Akt (Ser47), phospho GSK3β (Ser9)
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(Cell Signaling TECHNOLOGY, Boston, MA, USA) and cyclophilin D (Santa Cruz
Biotechnology, Santa Cruz, CA, USA). Membranes were incubated with a 1:1000 dilution of
horseradish peroxidase–labeled anti-rabbit immunoglobulin G (NA 934V, GE Healthcare,
Buckinghamshire, United Kingdom). The same blot was stripped and re-blotted with α-tubulin
antibodies

(Santa

Cruz

Biotechnology),

total

Akt

and

GSK3β

(Cell

Signaling

TECHNOLOGY). Bound antibody signals were detected with enhanced chemiluminescence
(Pierce Biotechnology, Rockford, IL, USA) and visualized using VersaDoc 5000 Imaging
System (Bio-Rad, Hercules, CA). Quantitative analysis of band densities was performed with
Quantity One software (Bio-Rad). Results are presented as the ratio of phospho Akt and
phospho GSK3β to total (including non-phosphorylated and phosphorylated protein) Akt and
GSK3β, respectively.

Studies in isolated cardiac mitochondria
To investigate involvement of MPTP in cardioprotection by autophagy, mitochondria
were isolated (n=4 per group). After perfused and treated with sevoflurane, chloramphenicol
and 3MA, isolated hearts were removed from the Langendorff apparatus, and homogenized
in ice-cold MSTEB buffer as previously described.17 Extracted mitochondria were diluted in
ice-cold respiratory buffer and incubated with 1µM calcein-AM (Invitrogen Molecular
Probes, Carlsbad, USA) for 15 min at room temperature. Calcein-AM readily enters the
mitochondria and is trapped in the matrix in its free form, which is fluorescent. After calcein
was trapped in mitochondria, mitochondria were washed by KCl buffer.17 Calcein-loaded
mitochondria were treated with 50 and 150 µM Ca++ per milligram of protein, and were
incubated for 10 min at room temperature. Mitochondrial fluorescences were acquired. Flow

10

cytometric analysis was performed on FACS calibur™ (Becton Dickinson, Franklin lakes,
NJ). Mitochondria labeled with calcein-AM were analyzed by flow cytometry in an
instrument equipped with a 488 nm excitation source.
Electron Microscopy
To confirm induction of autophagy, cardiac specimens were obtained before
sustained ischemia. They were fixed with phosphate-buffered 2.5 % glutaraldehyde (pH 7.4)
and were postfixed with 1 % osmium tetroxide, after which they were conventionally
prepared for transmission electron microscopy (H-800, Hitachi, Tokyo, Japan).
Statistical Analysis
Data are expressed as mean±SD. Statistical power analysis revealed a sample size of
n=8 would provide sufficient power (0.8) to detect a difference between mean infarct size
indices of 15 % (SD=9, α=0.05). A group size of n=4 was used for Western blot and calcein
studies to provide a power of 0.8 to detect a difference between means of 20% (SD=10,
α=0.05). Hemodynamic data were tested for normal distribution and subsequently analyzed
by a two-factor repeated-measures analysis of variance for time and treatment. If an overall
difference between variables was observed, comparisons were performed as one-way
ANOVA followed by Tukey's post-hoc test for inter-group differences and by Dunnett's for
intra-group differences with baseline values as the reference time point. Analyses of infarct
size, Western blot and mitochondrial calcein fluorescence were performed using one-way
ANOVA followed by Student's t-test with Bonferroni's correction for multiple comparisons
to avoid type I error. For changes within and between groups a two-tailed p value less than
0.05 was considered significant (SPSS17 for Windows, SPSS Japan, Tokyo, Japan).
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Results
Of 189 hearts, 7 were not used secondary to intractable ventricular fibrillation after
reperfusion (3 in CTL-45, 2 in CAP-45, 1 in SEVO-45+3MA and 1 in

SEVO-

45+CAP+3MA) and one due to aortic rupture. Additional hearts were studied until each
group had n=8 successful experiments for the infarct size study. The concentration of
sevoflurane in the coronary perfusate after 10 min of exposure was 0.25±0.02 mM.
Sevoflurane was not detected in the effluent during the baseline, ischemic, and reperfusion
periods.

Hemodynamics
Baseline LVDP and CF were similar among the 10 groups. Sevoflurane,
chloramphenicol or treatment with 3MA did not significantly affect LVDP or CF before
ischemia. After 120 min reperfusion, only SEVO-30 had significantly higher LVDP and
lower LVEDP compared to other groups. Treatment with 3MA alone did not affect the
recovery of LVDP compared with CTL. There was no significant difference in CF among all
the groups throughout experiments. This suggests that changes in CF could not account for
improved contractile recovery in SEVO-30 (Table 1).

Myocardial Infarct Size
Myocardial infarct size in SEVO-30 was significantly reduced compared with control
hearts (SEVO-30: 24±8% vs. CTL-30: 48±6%, p<0.05). However, this effect was lost when
the ischemic period was extended to 45 min (SEVO-45: 53±6% vs. CTL-45: 54±11%,
p=NS). Chloramphenicol restored protection lost by prolonged ischemia in SEVO-45
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(SEVO-45+CAP: 34±8% vs. SEVO-45: 52±10%, p<0.05). Restoration of cardioprotection
by chloramphenicol was abolished by 3MA (SEVO-45+CAP+3MA: 51±8% vs. CTL-45,
p=NS). Treatment with chloramphenicol alone did not limit infarct size (CAP-45: 51±9%)
(Figure 2).

Electron Microscopy
Figure 3 shows representative electron microphotographs. Although autophagic
vacuoles were rarely seen in cardiomyocytes of CTL (panel A), typical autophagosomes
containing intracellular organelles, such as mitochondria and membrane-like structures
(white arrows), were apparent after sevoflurane administration (panel B). Additional
treatment with chloramphenicol (panel C) further increased the number of autophagosomes.
Autophagosomes were diminished by addition of 3MA (panel D).

Western Blot analysis
In SEVO and CAP, LC3-II expression was increased compared with CTL. The
combination of sevoflurane and chloramphenicol further increased this expression. These
increased expressions of LC3-II were abolished by 3MA (Figure 4). The phosphorylation
states of Akt and GSK3β after treatment with sevoflurane, cloramphenicol and 3MA are
illustrated by a representative Western blot in Figure 5A. Total Akt and GSK3β were
comparable in all samples. The ratio of phospho Akt to total Akt and phospho GSK3β to
total GSK3β were significantly increased in SEVO and CAP compared with CTL (Figure
5B). This increase was not caused by unequal loading of the western blot, as shown by αtubulin detection. The combination of sevoflurane and chloramphenicol enhanced these
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increased expressions in SEVO-45+CAP. Administration of 3MA abolished these enhanced
expressions in SEVO-45+CAP. There was no significant difference in expression of
mitochondrial cyclophilin D between CTL and SEVO-45+CAP (Figure 5C).

Mitochondrial calcein fluorescence
The mitochondrial calcein fluorescence values after treatment with Ca2+ were taken
as the values from which any reduction in fluorescence was measured. Exposure of
mitochondria to 50 µM Ca2+ did not induce MPTP opening (Figure 6A). However, exposure
of mitochondria to 150 µM Ca2+ induced MPTP opening, represented by a reduction in
calcein fluorescence of -66.9±13.0% in CTL. This Ca2+-induced reduction in calcein
fluorescence was attenuated in the SEVO-45 and CAP-45 groups (-40.0±8.0%, -44.0±1.8%
vs. CTL-45, p<0.05, respectively; Figure 6B). This effect was enhanced by the SEVO45+CAP (-15.5±0.3% vs. SEVO-45 and CAP-45, p<0.05), which was then abrogated by
treatment with 3MA (SEVO-45+CAP +3MA: -74.6±7.8%) (Figure 6B).
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Discussion
This study demonstrated that induction of autophagy before ischemia restores the
loss of sevoflurane preconditioning cardioprotection with prolonged ischemic insult. This
effect is associated with enhanced phosphorylation of GSK3β before prolonged ischemia
which results in elevation of the threshold of MPTP opening by Ca2+ overload, but not
expression of mitochondrial cyclophilin D. There is a consensus that the use of volatile
anesthetics during perioperative period could be a promising strategy to reduce ischemiareperfusion injury for patients at risk of developing cardiac complications. However, the
beneficial effects of volatile anesthetics are limited to a certain range of sustained ischemia
durations. Thus, strategies that prolong the protective effect of volatile anesthetics during
longer ischemic insults should be explored. This study demonstrated for the first time that
chloramphenicol treatment could be a novel strategy for this purpose.
Chloramphenicol, used as an antibiotic, is a cytochrome P450 monooxygenase
inhibitor which inhibits mitochondrial protein synthesis, causing mitochondrial stress.
Chloramphenicol induces autophagy and preconditioning-like cardioprotection, but the
mechanisms underlying the cardioprotective effect remains to be established. Thus, we
examined whether treatment with chloramphenicol affects expression of mitochondrial
cyclophilin D, which is a component of MPTP that controls mitochondrial pore-dependent
Ca2+ exchange,18,19 and is a critical mediator of cardioprotection by ischemic
preconditioning. There were no significant differences in expression of mitochondrial
cyclophilin D between CTL and SEVO-45+CAP. This suggests that cyclophilin D is not
involved in cardioprotection by chloramphenicol. Chloramphenicol stimulates the
autophagic transcript Atg 12 by inhibiting mitochondrial protein synthesis, which results in
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induction of autophagy.20 This study found that pretreatment with chloramphenicol before
ischemia increased expression of LC3-II which leads to formation of autophagosomes. This
was confirmed by electron microscopy.
McCormick et al. demonstrated that enhancing autophagy confers protection against
ischemia-reperfusion injury in cardiomyocytes.21 Using in vivo swine models, Sala-Mercado
et al. showed that induction of autophagy by chloramphenicol before ischemia limited infarct
size.22 However, the precise mechanisms by which pre-ischemic induction of autophagy
confers cardioprotection remain to be elucidated. It has been demonstrated that induction of
autophagy during ischemia is protective whereas further enhancement of autophagy is
detrimental during reperfusion.23 Thus, it remains controversial whether autophagy is
beneficial or harmful in ischemia-reperfusion injury.
MPTP opening is a crucial determinant of ischemia-reperfusion injury.24 MPTP
opening has also been shown to induce autophagy.25 Elmore et al. demonstrated that
autophagic stimulation caused an increase in spontaneously depolarizing mitochondria
(presumably transient MPTP opening) in rat hepatocytes.26 Transient MPTP opening before
prolonged ischemia makes the heart more tolerant to ischemia-reperfusion injury.27,28 We
previously demonstrated that heart exposure to sevoflurane increased the threshold of MPTP
opening by Ca2+ loading.17 In the present study, exposure of control mitochondria to 150 µM
Ca2+ induced MPTP opening. This was attenuated in CAP and SEVO, and attenuated to an
even greater degree in SEVO+CAP. These data suggests that transient MPTP opening by
induction of autophagy with chloramphenicol increases the elevation of the threshold of
MPTP opening by sevoflurane alone.
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The threshold for MPTP opening is increased by phosphorylation of GSK3β at Ser9
through phosphatidylinositol 3-kinase (PI3K)/Akt signaling.16 Whether there is an
association between autophagy and GSK3β phosphorylation in reducing ischemiareperfusion injury is not known. Recently, it was reported that ultraviolet B-induced
autophagy activated AMP-activated protein kinase, an important regulator of autophagy
through inhibition/phosphorylation of GSK3β.29 Our data demonstrated that induction of
autophagy increased expression of phosphorylated GSK3β at Ser,9 accompanied by
increased Akt phosphorylation. Both sevoflurane and chloramphenicol have been shown to
activate PI3K/Akt signaling which is upstream of GSK3β.17,30 Class III PI3K is involved in
the formation of autophagosomes, whereas class I PI3K inhibits the induction of autophagy
via phosphorylation of Akt and the mammalian target of rapamycin (mTOR).31 Furthermore,
there is evidence of self-regulation of autophagy by autophagy-induced inhibition of
mTOR.32 Thus, the interaction of Akt with mTOR is multifaceted and bidirectional.
Nevertheless, our data suggest that autophagy and PI3K-Akt-mTOR signaling might yield
additive benefit against ischemia-reperfusion injury.
In contrast to the in vivo porcine study by Sala-Mercado et al,22 chloramphenicol
alone did not limit infarct size in the present study, despite increased expression of
autophagy-related protein LC3-II. However, chloramphenicol-induced autophagy did
prolong sevoflurane preconditioning cardioprotection after a longer ischemic insult.
Although the reason for the discrepancy remains to be elucidated, differences in ischemiareperfusion model and species could play a role.
The following study limitations should be acknowledged. First, GSK3β is a substrate
of multiple pro-survival protein kinases. We cannot exclude ity that kinases other than
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PI3K/Akt signaling contributed to enhanced phosphorylation of GSK3β. Second, the
pharmacokinetics of 3MA are not well known, especially at high doses. The dose of 3MA
used in this study (10 µM) was low compared to previous studies (5 mM or 5 nM).21,29
However, this dose has been shown to effectively block LC3-II expression in H9c2 cells as
was seen in this study.33
In conclusion, induction of autophagy by before ischemia restores the loss of
sevoflurane preconditioning cardioprotection with prolonged ischemic insult. This effect is
associated with enhanced phosphorylation of GSK3β before prolonged ischemia which is
associated with enhanced inhibition of MPTP opening.

3317 words
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Figure Legends
Figure 1: Schematic illustration of the experimental protocol used in this study. There are ten
groups. After 20 min baseline period, isolated perfused hearts were subjected to 30 or 45 min
global ischemia and 120min reperfusion. Anesthetic preconditioning was elicited by
administration of 10 min of SEVO (2%) with 10 min washout before 30 or 45 min ischemia.
CAP and 3-MA was administered starting 20 min before 45 min ischemia and throughout
the reperfusion period in hearts from SEVO-treated or non-SEVO-treated animals. Tissue
samples were obtained before ischemia. CTL, control; CAP, Chloramphenicol; 3-MA, 3Methyladenine; SEVO, sevoflurane.

Figure 2: Infarct size as a percentage of LV in ten groups. After 120min reperfusion, infarct
size was significantly reduced in SEVO-30 but not in SEVO-45 compared to corresponding
CTL. Treatment with CAP in SEVO-45 restored the protection lost by prolonged ischemia in
SEVO-45. CAP alone did not limit infarct size after 45 min of ischemia. Restoration of
cardioprotection achieved by CAP was abolished by 3MA. 3MA alone did not affect infarct
size. Data are presented as mean ± SD; *p<0.05 versus CTL-30; †p<0.05 versus SEVO-45.
CTL, control; CAP, Chloramphenicol; 3-MA, 3-Methyladenine; SEVO, sevoflurane (n=8 for
each group).

Figure 3: Electron microphotographs of cardiomyocytes, showing pre-ischemic induction of
autophagosomes by reagents. Autophagosomes were rarely seen in the untreated control
heart (panel A), were apparently observed (white arrows) after treatment with SEVO-45
(panel B). Autophagosomes appear to be more abundant after additional treatment with CAP
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(SEVO-45+CAP) compared with SEVO-45 alone (panel C). Appearance of autophagosomes
strikingly diminished after treatment with 3MA (panel D). Nucl, nucleus. Bars, 1 µm.

Figure 4: Representative western blot analysis of LC3-I, II from left ventricular samples
obtained before ischemia. The expression of LC3-II was slightly increased in SEVO and
CAP compared to CTL. The ratio of LC3-II to LC3-I (LC3-II/LC3-I) was further increased
in SEVO-45+CAP compared to SEVO-45 and CAP-45. Administration of 3-MA abolished
this increased LC3-II/I in the SEVO-45+CAP group. *p<0.05 versus CTL, †p<0.05 versus
SEVO-45 and CAP-45; CAP, Chloramphenicol; LC3-I, II, microtubule-associated protein
light chain I and II; 3-MA, 3-Methyladenine; SEVO, sevoflurane.

Figure 5: (A) Representative western blot of phosphorylated GSK3β from left ventricular
samples acquired before ischemia. Expression of phosphorylated GSK3β was significantly
increased in the SEVO-45 and CAP-45 group. The combination of SEVO and CAP further
increased this expression of phosphorylated GSK3β and Akt in the SEVO-45+CAP group.
Administration of 3MA abolished this enhanced expression of phosphorylated GSK3β in the
SEVO-45+CAP group.
(B) Densitometric evaluation of four experiments as the x-fold increase in average light
density vs. CTL. The results are presented as the ratio of the phosphorylation state to total
protein. The average light intensity was multiplied by 100 to facilitate the presentation of an
x-fold increase. Data are presented as mean standard deviation. *p<0.05 versus CTL-45,
†

p<0.05 versus SEVO-45, CAP-45 and SEVO-45+CAP+3MA
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(C) Cytosolic and mitochondrial expression of cyclophilin D in CTL, CAP-45 and SEVO45+CAP. There was no significant difference in expression between the three groups.
CTL, control; CAP, Chloramphenicol; CyF D, cyclophilin D; GSK3β, glycogen synthase
kinase-3; 3-MA, 3-methyladenine; PHB, prohibitin; SEVO, sevoflurane.

Figure 6: (A) Representative flow cytometric profile of isolated cardiac mitochondria loaded
with calcein showing the effects of calcium (50 µM) on mPTP opening as demonstrated by
reductions in mitochondrial calcein fluorescence. Exposure of mitochondria to 50 µM Ca2+
did not induce MPTP opening in any group. (B) Exposure of mitochondria to 150µM Ca2+
induced MPTP opening in CTL. This Ca2+-induced reduction in calcein fluorescence was
attenuated in SEVO and CAP. This effect was enhanced by the combination of sevoflurane
and chloramphenicol, which was then abrogated by treatment with 3MA. (C) Effect of
calcium (150µM) on MPTP opening as demonstrated by reductions in mitochondrial calcein
fluorescence. Data are mean ± S.D. Percent change from control in the presence or absence
of 3-MA (10 µM). *p<0.05 versus CTL-45; †p<0.05 versus SEVO-45 and CAP-45 groups.
CTL, control; CAP, Chloramphenicol; 3MA, 3-Methyladenine; SEVO, sevoflurane. n=4 for
each group

Figure

7:

Schematic

diagram

of

potential

mechanisms

of

autophagy-induced

cardioprotection conferred by chloramphenicol and sevoflurane. Phosphorylation of GSK3β
by PI3-Akt pathway inhibits MPTP opening. Class III PI3K is involved in formation of
autophagosomes whereas class I PI3K inhibits the induction of autophagy via
phosphorylation of Akt and mTOR. Treatment with chloramphenicol or sevoflurane alone
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activates class III PI3K to induce autophagy. Simultaneous treatment with chloramphenicol
and sevoflurane enhances this pathway which results in enhanced phosphorylation of GSK3β
and elevation of the threshold of MPTP opening.
PI3K = phosphatidylinositol 3-kinase; Akt = protein kinase B; GSK3β = glycogen synthase
kinase 3β; mTOR = mammalian target of rapamycin; MPTP = mitochondrial permeability
transition pore.
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Table 1
TABLE 1.

Hemodynamic Variables
Baseline

LVDP (mmHg)
CTL-30
SEVO-30
CTL-45
SEVO-45
CAP+45
SEVO-45+CAP
CTL-45+3MA
SEVO-30+3MA
SEVO-45+3MA
CAP-45+3MA
CAP-45+SEVO+3MA
LVEDP (mmHg)
CTL-30
SEVO-30
CTL-45
SEVO-45
CAP+45
SEVO-45+CAP
CTL-45+3MA
SEVO-30+3MA
SEVO-45+3MA
CAP-45+3MA
SEVO-45+CAP+3MA
CF (mL)
CTL-30
SEVO-30
CTL-45
SEVO-45
CAP+45
SEVO-45+CAP
CTL-45+3MA
SEVO-30+3MA
SEVO-45+3MA
CAP-45+3MA
SEVO-45+CAP+3MA

Reperfusion (min)
60

30

109
103
108
101
109
101
117
97
95
105
97

±
±
±
±
±
±
±
±
±
±
±

11
13
13
10
11
14
12
14
10
15
11

39
61
21
23
21
21
18
44
23
25
19

±
±
±
±
±
±
±
±
±
±
±

8
9*
6
11
7
5
6

10
10
10
10
10
10
10
10
10
10
10

±
±
±
±
±
±
±
±
±
±
±

0
0
0
0
0
0
0
0
0
0
0

47
24
67
55
53
53
68
27
72
63
59

±
±
±
±
±
±
±
±
±
±
±

28
31
29
28
28
34
37
29
27
31
31

± 6
± 7
± 7
± 10
± 3
± 4
± 6
± 8
± 5
± 9
± 9

21
23
18
19
19
18
20
18
13
20
19

± 5
± 4
± 8
± 11
± 5
± 5
± 8
± 7
± 5
± 9
± 7

120

16 ̷
15
11
9

32
58
25
24
21
22
20
47
24
23
26

±
±
±
±
±
±
±
±
±
±
±

12
8*
13
10
6
5
7
17
14
10
16

26
50
24
23
21
21
17
44
20
20
26

±
±
±
±
±
±
±
±
±
±
±

9
8*
9
9
6
4
6
17
16
10
16

14
7*
7
13
10
6
8
7*
19
12
15

51
24
57
50
48
51
66
25
62
57
51

±
±
±
±
±
±
±
±
±
±
±

18
5*
13
11
10
10
10
9*
17
15
15

55
26
53
47
45
49
66
25
60
52
44

±
±
±
±
±
±
±
±
±
±
±

15
7*
14
12
10
11
11
9*
19
19
16

21
22
18
17
18
19
18
19
13
19
19

± 5
± 5
± 10
± 11
± 6
± 9
± 8
± 11
± 5
± 9
± 7

20
22
18
17
18
19
18
20
11
19
18

± 8
± 6
± 9
± 11
± 7
± 9
± 8
± 11
± 5
± 9
± 6
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Data are presented as mean ± SD. LVDP=left ventricular developed pressure; LVEDP=left
ventricular end-diastolic pressure; CF=coronary flow; CTL=control;CAP=chloramphenicol;
3MA=3-Methyladenine; SEVO=sevoflurane;. *p<0.05 vs. CTL-30, ̷ p<0.05 vs. SEVO-30
n=8 for each group.
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